After Uzbekistan Health Ministry alleged Indian company Marion Biotech cough syrup responsible for the death of 18 children, a joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team.
The Central Drugs Standard Control Organisation (CDSCO) is in regular contact with the national drug regulator of Uzbekistan regarding the matter.
“Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report”, said union health ministry on Thursday.
The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing. Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product. Marion Biotech is a licensed manufacturer and holds license for manufacturing of Dok1 Max syrup and Tablet for export purpose granted by Drugs Controller, Uttar Pradesh.
WHO South-East Asia Region (SEAR) faces a disproportionately high burden of work-related mortality, with 36.5…
Cervical cancer is a culturally sensitive disease given its transmission through the sexual route and…
All India Organization of Chemists and Druggists (AIOCD) has expressed deep concern over the Central…
The National Medical Commission has formed a National Task Force on Mental Health and Wellbeing…
Fortis Healthcare has launched ‘Adayu Mindfulness’, a dedicated vertical for comprehensive Mental Healthcare along with…
A group of genes could be common to both depression and heart disease, a finding…